Login to Your Account



FIRST APPROVED THERAPY

Auxilium stock up on FDA approval of Peyronie’s therapy

By Catherine Shaffer
Staff Writer

Friday, December 6, 2013
The FDA approved Xiaflex (collagenase clostridium histolyticum) for Peyronie’s disease, making it the first approved therapy for the condition, which is characterized by abnormal tissue in the penis, causing a curvature deformity of at least 30 degrees upon erection.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription